Skip to content

Clinical trials

Phase 3 Melanoma trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 3 Country / region: Norway Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20081
20091
20101
20111
20123
20135
20152
20171
20181
20191
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated5
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb9
Novartis Pharmaceuticals4
Hoffmann-La Roche3
European Organisation for Research and Treatment of Cancer - EORTC2
GlaxoSmithKline2
Pfizer2
Eli Lilly and Company1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma24
Neoplasms4
Neoplasm Metastasis3
Skin Neoplasms3
Brain Neoplasms1
Fever1
Skin Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.